Tuomo Tapani Pätsi
Chairman bei FARON PHARMACEUTICALS OY
Vermögen: 43 594 $ am 31.03.2024
Profil
Tuomo Tapani Pätsi is currently the Chairman at Faron Pharmaceuticals Oy and Notable Labs Ltd.
He previously worked as the Co-Managing Director at Juno Therapeutics GmbH, Director at Celgene Ltd., Director at Celgene Europe Ltd., Vice President-European Region at Human Genome Sciences, Inc., Executive VP-Commercial International at Seagen Inc., and President-Europe, Middle East & Africa Region at Celgene International SARL.
He graduated from the University of Helsinki.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
FARON PHARMACEUTICALS OY
0,04% | 03.04.2024 | 25 098 ( 0,04% ) | 43 594 $ | 31.03.2024 |
Aktive Positionen von Tuomo Tapani Pätsi
Unternehmen | Position | Beginn |
---|---|---|
FARON PHARMACEUTICALS OY | Chairman | 05.04.2024 |
Aqsens Health Oy
Aqsens Health Oy Medical/Nursing ServicesHealth Services Aqsens Health Oy is a Finnish health and biotechnology start-up that specializes in developing non-invasive screening tests for high-impact diseases. The private company is located in Finland. The Finnish company's current research focuses on developing a mobile screening platform for infectious diseases and a reliable prostate cancer screening test using their e-trf technology and novel phage-based biosensors. The company's non-invasive screening and diagnostics technology is based on the e-trf method and bacteriophage biosensors. | Director/Board Member | 01.04.2023 |
Ehemalige bekannte Positionen von Tuomo Tapani Pätsi
Unternehmen | Position | Ende |
---|---|---|
SEAGEN INC. | Corporate Officer/Principal | 04.02.2022 |
Celgene Ltd.
Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | Director/Board Member | 30.04.2020 |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the private company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Chief Executive Officer | - |
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK. | Director/Board Member | - |
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Corporate Officer/Principal | - |
Ausbildung von Tuomo Tapani Pätsi
University of Helsinki | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FARON PHARMACEUTICALS OY | Health Technology |
Private Unternehmen | 7 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the private company is based in Boudry, Switzerland. | Health Technology |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the private company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Health Technology |
Celgene Ltd.
Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | Health Technology |
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK. | Health Technology |
Aqsens Health Oy
Aqsens Health Oy Medical/Nursing ServicesHealth Services Aqsens Health Oy is a Finnish health and biotechnology start-up that specializes in developing non-invasive screening tests for high-impact diseases. The private company is located in Finland. The Finnish company's current research focuses on developing a mobile screening platform for infectious diseases and a reliable prostate cancer screening test using their e-trf technology and novel phage-based biosensors. The company's non-invasive screening and diagnostics technology is based on the e-trf method and bacteriophage biosensors. | Health Services |